eNauka - pregled

Pregled prema Autor Babovic, Nada Lj

Prikaz rezultata 1 do 15 od 15
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2000Addition of medroxyprogesterone-acetate (MPA) to interferon-alpha (IFN) vinblastine (VLB) combination in advanced renal-cell carcinoma (RCC) - is there any impact on quality of life (QoL)?Radosavljevic, Davorin Z; Jelic, Svetislav B; Babovic, Nada Lj; Popov, Ivan P; Kreacic, Miroslav; Stamatovic, Ljiljana; Nikolic-Tomasevic, Zorica I  ; Kezic, IvaKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2019AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan)Todorovic, Vladimir; ...; Babovic, Nada Lj; ...; Četniković, Bojana; Ceric, Timur; ...; Dzamic, Zoran M  ; Dzodic, Radan R ; Eri, Živka ;
...; Knežević-Ušaj, Slavica F ; Kovcin, Vladimir N; ...; Markovic, Ivan Z; Markovic, Milan; Mijalkovic, Nenad; ...; Pantelic, Aleksandra; Popović, Lazar S  ; Radosavljevic, Davorin Z; ...; Radulovic, Sinisa S; ...; Rosic, Ivana; ...; Stamatović, Ljiljana  ; ...; Tesanovic, Dusanka D; Tomasevic, Zorica I  ; Tomasevic, Zoran M; ...; Vasovic, Suzana; Vicko, Ferenc  ; ...; Zarić, Bojan  ; ...; (broj, koautora 65);
Naučni članak
23M23 - Međunarodni časopis kategorije M23
2009Association of Impaired NK Cell Activity with Imbalance in CD3-CD16+Bright and Dim Subset Distribution and Receptor Expression in Metastatic Melanoma PatientsKonjevic, Gordana M; Mirjacic-Martinovic, Katarina M; Vuletic, Ana M  ; Babovic, Nada LjKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2009Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: Decreased NKG2D and increased CD158a receptors on CD3-CD16+NK cellsKonjevic, Gordana M; Mirjacic-Martinovic, Katarina M; Jurisic, Vladimir B  ; Babovic, Nada Lj; Spuzic, IvanNaučni članak
21M21 - Vodeći međunarodni časopis kategorije M21
2000Cisplatin dose intensity in poor risk germ cell tumors.Babovic, Nada Lj; Jelic, Svetislav B; Stamatovic, LjiljanaKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2002Comparison of the efficacy of two different dosage dacarbazine-based regimens and two regimens without dacarbazine in metastatic melanoma: a single-centre randomized four-arm studyJelic, Svetislav B; Babovic, Nada Lj; Kovcin, Vladimir N; Milicevic, N; Milanovic, Nenad; Popov, Ivan P; Radosavljevic, Davorin ZNaučni članak
21M21 - Vodeći međunarodni časopis kategorije M21
1999Epirubicin 150 mg/m(2)-cisplatin versus epirubicin 180 mg/m(2)-cisplatin for advanced soft tissue sarcomaJelic, Svetislav B; Babovic, Nada Lj; Kreacic, Miroslav; Matkovic, Suzana; Milanovic, Nenad; Gavrilovic, Dusica; Tomasevic, Zoran MNaučni članak
23M23 - Međunarodni časopis kategorije M23
2008Molecular targeting agents in renal cell carcinoma: Present strategies and future perspectivesBjelogrlic, Snezana K; Radulovic, Sinisa S; Babovic, Nada LjNaučni članak
21aM21a - Vodeći međunarodni časopis kategorije M21a
2000Paclitaxel-cisplatin as first line chemotherapy for undifferentiated carcinoma of the nasopharynx (UCNT): A preliminary report.Jelic, Svetislav B; Babovic, Nada Lj; Stamatovic, Ljiljana; Vucicevic, Slavko S; Pendjer, Ivica P; Radulovic, Sinisa SKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2008Potentiation of Cisplatin (Cddp) Activity with Cytarabine (Car) In The 5-Fu-Cddp Regimen In Neoadjuvant Setting Significantly Prolongs Survival In Patients with Locally Advanced Head and Neck Cancer ( Hnc); A Study In 334 PatitentsJelic, Svetislav B; Kreacic, Miroslav; Vucicevic, Slavko S; Gavrilovic, Dusica; Jovanovic, Natasa; Petrovic, Zeljko M; Ursulovic, Tamara B; Mikic, Anton A; Babovic, Nada LjKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2000Primary non-Hodgkin lymphoma of the breast. Is it possible to avoid mastectomy?Babovic, Nada Lj; Jelic, Svetislav B; Jovanovic, VNaučni članak
23M23 - Međunarodni časopis kategorije M23
2001Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III studyJelic, Svetislav B; Mitrovic, LB; Radosavljevic, Davorin Z; Elezar, E; Babovic, Nada Lj; Kovcin, Vladimir N; Tomasevic, Zorica I  ; Kovacevic, S; Gavrilovic, Dusica; Radulovic, Sinisa SNaučni članak
21M21 - Vodeći međunarodni časopis kategorije M21
2017Treatment of nasopharyngeal cancer: a Serbian institututinal experienceUrsulovic, Tamara B; Babovic, Nada LjKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2002Use of high-dose cytarabine to enhance cisplatin cytotoxicity - effects on the response and overall survival rates of advanced head and neck cancer patientsJelic, Svetislav B; Stamatovic, Ljiljana; Vucicevic, Slavko S; Petrovic, Zeljko M; Kreacic, Miroslav; Babovic, Nada Lj; Jovanovic, Natasa; Mikic, Anton A; Gavrilovic, DusicaNaučni članak
21M21 - Vodeći međunarodni časopis kategorije M21
2001Vinblastin-carboplatin for metastatic cutaneous melanoma as first-line chemotherapy and in dacarbazine failures - A single-center studyJelic, Svetislav B; Babovic, Nada Lj; Stamatovic, Ljiljana; Kreacic, Miroslav; Matkovic, Suzana; Popov, Ivan PNaučni članak
22M22 - Međunarodni časopis kategorije M22